The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Tackling neurodegenerative diseases with genomic engineering: A new stem cell initiative from the NIH
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent hiPSC genetic modeling efforts have utilized either a pooled patient iPSC strategy to uncover disease phenotypes in the context of patient genetic heterogeneity or a comprehensive isogenic platform to assess the effect of disease mutations by limiting genetic background variation (Lim et al., 2020; Mitchell et al., 2020; Ramos et al., 2021).”
From Cholesterol and matrisome pathways dysregulated in astrocytes and microglia (2022) · cites this paper as Ramos et al., 2021
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A comprehensive resource for induced pluripotent stem cells from patients with primary tauopathies
Karch, C. M., Kao, A. W., Karydas, A., Onanuga, K., Martinez, R., Argouarch, A., Wang, C., Huang, C., Sohn, P. D., Bowles, K. R., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.09.006 · Cited by 119
Flagged first, then by citations
Research works printed but not linked: 9
- Abud, 2017, iPSC-Derived Human Microglia-like Cells to Study Neurological Diseases, Neuron, 94, 278, 10.1016/j.neuron.2017.03.042 · DOI · Paper page
- Konttinen, 2019, PSEN1ΔE9, APPswe, and APOE4 Confer Disparate Phenotypes in Human iPSC-Derived Microglia, Stem Cell Reports, 13, 669, 10.1016/j.stemcr.2019.08.004 · DOI · Paper page
- Kwart, 2019, A Large Panel of Isogenic APP and PSEN1 Mutant Human iPSC Neurons Reveals Shared Endosomal Abnormalities Mediated by APP β-CTFs, Not Aβ, Neuron, 104, 256, 10.1016/j.neuron.2019.07.010 · DOI
- Marek, 2011, The Parkinson Progression Marker Initiative (PPMI), Prog. Neurobiol., 95, 629, 10.1016/j.pneurobio.2011.09.005 · DOI
- Rothstein, 2020, Answer ALS: A Large-Scale Resource for Sporadic and Familial ALS Combining Clinical Data with Multi-Omics Data from Induced Pluripotent Cell Lines, Research Square
- Slanzi, 2020, In vitro Models of Neurodegenerative Diseases, Front. Cell Dev. Biol., 8, 328, 10.3389/fcell.2020.00328 · DOI
- Streeter, 2017, The human-induced pluripotent stem cell initiative-data resources for cellular genetics, Nucleic Acids Res., 45, D691, 10.1093/nar/gkw928 · DOI · Paper page
- Wang, 2017, Scalable Production of iPSC-Derived Human Neurons to Identify Tau-Lowering Compounds by High-Content Screening, Stem Cell Reports, 9, 1221, 10.1016/j.stemcr.2017.08.019 · DOI · Paper page
- Xiong, 2016, CRISPR/Cas9 for Human Genome Engineering and Disease Research, Annu. Rev. Genomics Hum. Genet., 17, 131, 10.1146/annurev-genom-083115-022258 · DOI
Cited by
Sorted by citations
Cholesterol and matrisome pathways dysregulated in astrocytes and microglia
TCW, J., Qian, L., Pipalia, N. H., Chao, M. J., Liang, S. A., Shi, Y., Jain, B. R., Bertelsen, S. E., Kapoor, M., Marcora, E., et al. (2022) · Cell · doi:10.1016/j.cell.2022.05.017 · Cited by 411
Artificial intelligence for dementia genetics and omics
Bettencourt, C., Skene, N., Bandres‐Ciga, S., Anderson, E., Winchester, L. M., Foote, I. F., Schwartzentruber, J., Botia, J. A., Nalls, M., Singleton, A., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13427 · Cited by 30
Self-citationLomoio, S., Pandey, R. S., Rouleau, N., Menicacci, B., Kim, W., Cantley, W. L., Haydon, P. G., Bennett, D. A., Young-Pearse, T. L., Carter, G. W., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02147-3 · Cited by 25
Metadata
- Authors
- Ramos, D. M., Skarnes, W. C., Singleton, A. B., Cookson, M. R., & Ward, M. E.
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 2021-04
- Volume
- 109
- Issue
- 7
- Pages
- 1080-1083
- ISSN
- 0896-6273
- PMC
- PMC8985232
- Cited by
- 107
- References
- 1
- Language
- en
- Licence
- Funders
- National Institutes of Health
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
